Ignite Creation Date:
2024-05-06 @ 4:02 AM
Last Modification Date:
2024-10-26 @ 11:42 AM
Study NCT ID:
NCT02434562
Status:
COMPLETED
Last Update Posted:
2017-01-25
First Post:
2015-04-30
Brief Title:
Development and Validation of in Vitro Cell-based Bioassays for Nuclear Receptor Activation
Sponsor:
Universitaire Ziekenhuizen KU Leuven
Organization:
Universitaire Ziekenhuizen KU Leuven
Study Overview
Official Title:
Development and Validation of in Vitro Cell-based Bioassays for Nuclear Receptor Activation by Human Serum
Status:
COMPLETED
Status Verified Date:
2016-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a prospective biobank set up to collect serum from patients with disorders associated with changes in androgens estrogens or sex hormone-binding globulin SHBG before andor after treatment
Detailed Description:
In vitro cell-based bioassays may be a technique to measure serum androgen or estrogen bioactivity In this study investigators are collecting serum and if possible urine samples from different cohorts of patients before andor after treatment
The aim is to measure androgens estrogens and SHBG as well as in vitro bioactivity with newly developed cell-based bioassays and to compare different techniques to each other as well as to clinical endpoints available in the patients Electronic Health Record
The aim is to measure androgens estrogens and SHBG as well as in vitro bioactivity with newly developed cell-based bioassays and to compare different techniques to each other as well as to clinical endpoints available in the patients Electronic Health Record
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None